Archive | Clinical Trials

CheckMate 204 Update: Practice-Changing for Brain Metastases?

I am Jeffrey Weber, a medical oncologist at the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health in New York City.

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials

ONCOS-102, Keytruda Combo May Reduce Tumor Size in Treatment-resistant Melanoma, Early Trial Data Show

Melanoma patients who become resistant to immune checkpoint inhibitors may regain susceptibility to such treatments after receiving Targovax‘s immune activator ONCOS-102, early clinical trial findings suggest.

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials

A prospective trial of adjuvant therapy for high-risk uveal melanoma: Assessing 5-year survival outcomes

Because survival after diagnosis of uveal melanoma metastasis is poor, researchers conducted an adjuvant trial of sequential, low-dose dacarbazine (DTIC) and interferon-alpha-2b (IFN-??2b) in patients with cytogenetic high-risk uveal melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials

Standardization Arrives for Neoadjuvant Trials in Melanoma

The International Neoadjuvant Melanoma Consortium (INMC) recently published a comprehensive set of recommendations for the design and implementation of clinical trials that aim to assess neoadjuvant therapy in high-risk resectable melanoma patients in Lancet Oncology.

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials